Articles in this Issue
Patti Seymour, Dawn M. Ecker
As the number of commercial products and pipeline candidates grows, a crucial issue facing the industry is the current and future state of biomanufacturing capacity.
D.P. Elder
The use of medicinal products is always a compromise between acceptable risks and likely benefits, the same is not true for impurities.
The latest technologies in controlled release are formulated not only to provide specific release
characteristics, but also include one or more other functionalities.
Sulaf Assi, Louise Fortunato
Handheld Raman spectroscopy has emerged over the last few years as a rapid technique for authenticating medicines.
A number of approaches have been developed to improve the solubility of an API including particle size control and chemical modifications.
Martina Catani, Omar H. Ismail, Simona Felletti, Francesco Gasparrini, Luisa Pasti, Valentina Costa, Alberto Cavazzini
During the last decade, column manufacturers have put much effort into the design and preparation of materials suitable for highly efficient and fast separations in UHPLC.
Bruker provides a full suite of analysis capabilities from simple manipulations to the intricate evaluations.
Yan Wang, Wen Qu, Stephanie H. Choi
Polylactide (PLA)/Poly(lactide-co-glycolide) (PLGA) is widely used in many FDA-approved drug products.
Frank Delaglio, Gregory S. Walker, Kathleen Farley, Raman Sharma, Jeff Hoch, Luke Arbogast, Robert Brinson, John P. Marino
Nuclear Magnetic Resonance (NMR) spectroscopy is an indispensable tool in the pharmaceutical industry, with uses in drug discovery, development, and manufacturing.
Dr. Danny K. Chou, PharmD, PhD, Dr. Mitra Mosharraf, PharmD, PhD, Dr. Rajiv Nayar, PhD, Dr. Michael F. Drenski, PhD
Therapeutic proteins are challenging to develop and manufacture because their marginal stability makes them prone to denaturation and aggregation during purification, storage, distribution, and administration.
Emilie Branch
Recent data has shed light on the link between the human microbiome and the effectiveness of immunotherapeutics.
Harshada Sant, MS, Amitkumar Lad, PhD, Hemant N. Joshi, Ph.D., MBA
The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in February-March, 2017.